Posted by Clinical Lab Products | Aug 1, 2003 | Miscellaneous |
By Nicholas Borgert A number of factors are influencing the future of domestic drugs of abuse testing (DAT). While clinical DAT continues to be stable with some growth, workplace testing—a major component of nonclinical drug testing—ha
Read MorePosted by Clinical Lab Products | Jul 9, 2003 | Cancer, Miscellaneous |
Roche launches pharmacogenomic microarray
Read MorePosted by Clinical Lab Products | Jul 4, 2003 | Clinical Chemistry, Clinical Chemistry Analyzers, Clinical Chemistry Test Kits, Miscellaneous, POC Instruments |
Taming the matrix effect in POC glucose strip testing
Read MorePosted by Clinical Lab Products | Jun 9, 2003 | Cancer, Miscellaneous |
PSA test for prostate cancer should be repeated before biopsy The prostate specific antigen (PSA) blood test is used in routine prostate cancer screening for men over 50, and elevated PSA levels typically result in referral for a prostate biopsy.
Read MorePosted by Clinical Lab Products | Jun 8, 2003 | Miscellaneous |
CK-MB, myoglobin, troponin I and BNP in 15-minute meter format
Read More